TYME – Automated Leukemia Adherence Calendars

• Automated Adherence Calendars •

Save time.

Save Lives.

Acute lymphoblastic leukemia (ALL) is the most common form of childhood cancer.

Adherence calendars are difficult to generate in EHR platforms.

As a result, many physicians use time-consuming spreadsheets

…or nothing at all, leaving adherence in the hands of patients.

• The problem of Nonadherence •

“… relapsed ALL accounts for more deaths from cancer in children than any other malignancy.” [1]

Complex, long-term maintenance chemotherapy protocols pose significant hurdles to patient outcomes. [1, 2]

44%

of ALL patients nonadherent during outpatient maintenance therapy

2.5x

greater likelihood of relapse when more than one dose of 6MP missed per month

less likely to survive after relapse compared to initial diagnosis

• for a solution •

• FEATURES •

Intuitive UI allows clinicians to generate patient-specific calendars in seconds instead of minutes.
Error-free dosing calculations (incl. dose adjustments) and scheduling integrates COG maintenance protocols with patient-specific dosing parameters.
Printable calendars in two formats with options for color coding of meds & multiple languages make it easy for patients to follow.
Web-based app launched from within web browser.
Option to integrate with EHR upon request.

Created by the father of a childhood leukemia survivor

Automated and easy for physicians to use ♥ Simple for patients and caregivers to follow

Save time. Save lives.

• References •

[1] Raetz EA, Bhatla T. Where do we stand in the treatment of relapsed acute lymphoblastic leukemia? Hematol Am Soc Hematol Educ Program 2012;2012:129-136

[2] Bhatia S, Landier W, Shangguan M, et al. Nonadherence to oral mercaptopurine and risk of relapse in Hispanic and non-Hispanic white children with acute lymphoblastic leukemia: A report from the Children’s Oncology Group. J Clin Oncol 2012;30:2094-2101